Cyto-Facto Inc.

Corporate Identity・Mission

To improve lives in Japan and beyond by swift and reliable delivery of novel CGT (cell & gene therapy) products

News

2024/06/12【NEWS】Publication Information

2024/05/02【NEWS】Signing ceremony for MOU between Cyto-Fact Inc. and CellTech Innovation Venture Studio Co., Ltd.

2024/04/22【NEWS】Cyto-Facto Inc. has raised 1.18 billion Yen through third-Party allocation shares as Series A.

2024/04/01【NEWS】Notice of Head office New Location

2023/10/02【Seminar】Webinar with VAISALA by our CEO, Shin Kawamata

Past Publication Information